Americord’s In-House Lab Safety and Security

Americord is a leading provider of biobanking and health screening services, dedicated to helping families live longer, healthier lives. Our pristine in-house lab is located in Franklin Township, New Jersey.

At the Americord lab, expectant parents can feel confident in the safety and security of their baby’s stem cells. The lab is equipped with the latest technologies and is staffed by highly trained professionals. Our team members follow strict protocols and adhere to the highest standards of quality control.

We understand that the magnitude of this investment may make some families question the safety and security of the stem cells themselves, so we have outlined some of the measures we take to keep your baby’s stem cells safe and secure for decades.

Americord utilizes a multi-layered security infrastructure to ensure the long-term viability, privacy, and safety of banked stem cells. Our protocols focus on physical security, data de-identification, and redundant environmental monitoring.

1. Physical Facility Security
The laboratory is protected by a series of rigorous access controls to prevent unauthorized entry:

• Secure Access Points: Three key-coded secure doors exist between the facility entrance and the in-house laboratory.
• Authorized Personnel Only: Elevators and laboratory entry points require granted passes, limiting access strictly to trained Americord staff.

2. Specimen Privacy and De-identification
To prioritize client confidentiality, Americord employs a de-identification strategy during the processing phase:

• Unique Coding: Each individual unit is assigned a specific code for future identification.
• Restricted Mapping: The link between client identities and specific codes is restricted to a minimal number of authorized employees.
• Privacy Assurance: This "blind" storage system ensures that specimens cannot be matched to specific families by unauthorized parties, even within the facility.

3. Cryogenic Storage and Environmental Monitoring
Stem cells are preserved in advanced nitrogen tanks maintained at ultra-low temperatures. To ensure 24/7 viability, we utilize a dual-monitoring system:

• On-site Monitoring: Laboratory teams monitor tanks equipped with 24/7 localized alarms.
• Remote Surveillance (Tutela): Temperature sensors and ultra-low freezer probes report data to an interface monitored by Tutela. This third-party service provides remote alerts to key employees if temperatures deviate from the calibrated range.

4. Disaster Recovery and Emergency Preparedness
Americord maintains a comprehensive hazard mitigation plan to protect biological assets from natural disasters:

• Hardened Storage: Cryopreservation tanks are hermetically sealed to withstand external environmental influences.
• Emergency Relocation: Through a strategic partnership with GenVault, Americord ensures the immediate extraction and secure transfer of all tanks to a secondary location in the event of a facility-wide threat.

Americord operates a state-of-the-art, in-house laboratory designed for the high-efficiency processing and long-term preservation of neonatal biological materials. By maintaining internal control of the laboratory environment, Americord ensures rapid response times and rigorous safety standards.

1. Operational Excellence and Security

Since its inception, the in-house laboratory has maintained a flawless safety record with no major security or operational incidents.

• Rapid Response: Direct oversight allows for immediate technical adjustments and maintenance.
• Expert Oversight: Lab technicians are specialized in cryopreservation and trained to manage real-time alerts with high efficiency.
• Quality Commitment: The facility represents a multi-year investment in advanced biobanking infrastructure.

2. Comprehensive Biobanking Services

The Americord facility is equipped to process a diverse range of biological materials, each offering unique therapeutic potential:

• Cord Blood
  • Clinical Status: FDA-Approved.
  • Primary Use Case: Currently used in the treatment of over 80 conditions and diseases, including various hematopoietic and genetic disorders.
• Cord Tissue
  • Clinical Status: Clinical Trial Phase.
  • Primary Use Case: Focused on regenerative medicine and future therapeutic research for tissue repair.
• Placental Tissue
  • Clinical Status: Clinical Trial Phase.
  • Primary Use Case: Investigational treatments aimed at managing various chronic conditions and inflammatory diseases.
• Exosomes
  • Clinical Status: Clinical Trial Phase.
  • Primary Use Case: Cutting-edge research into advanced cellular communication and non-invasive healing modalities.

3. Industry Leadership and Compliance

Americord’s laboratory serves as a benchmark in the cord blood banking industry through:

• Advanced Technology: Integration of cutting-edge processing hardware and environmental monitoring.
• Experienced Staffing: A team dedicated exclusively to the nuances of neonatal stem cell preservation.
• Future-Proofing: Ongoing commitment to quality that ensures specimens remain viable and ready for future medical breakthroughs.

The views, statements, and pricing expressed are deemed reliable as of the published date. Articles may not reflect current pricing, offerings, or recent innovations.